These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14714699)

  • 1. Commentary on the panel presentations.
    Newman P
    Adv Genet; 2003; 50():355-9; discussion 507-10. PubMed ID: 14714699
    [No Abstract]   [Full Text] [Related]  

  • 2. When the human genome project and state street collide.
    Locke SD; Kalow DA
    Nat Biotechnol; 2000 Sep; 18(9):1009-10. PubMed ID: 10973226
    [No Abstract]   [Full Text] [Related]  

  • 3. Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA.
    Cockburn IM
    Adv Genet; 2003; 50():385-98; discussion 507-10. PubMed ID: 14714701
    [No Abstract]   [Full Text] [Related]  

  • 4. (Mostly) against exceptionalism.
    Wagner RP
    Adv Genet; 2003; 50():367-82; discussion 507-10. PubMed ID: 14714700
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to: Listening behind the questions--how experts can improve the public discourse on gene patenting.
    Warburg RJ
    Pharmacogenomics; 2003 Jul; 4(4):509-10. PubMed ID: 12831328
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology's uncertainty principle.
    Burk DL; Lemley MA
    Adv Genet; 2003; 50():305-53; discussion 361-6, 507-10. PubMed ID: 14714698
    [No Abstract]   [Full Text] [Related]  

  • 7. Some empirical evidence on how technologically complex issues are decided in patent cases in U.S. District Courts.
    McKelvie RR
    Adv Genet; 2003; 50():459-70; discussion 507-10. PubMed ID: 14714706
    [No Abstract]   [Full Text] [Related]  

  • 8. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.
    Jiang L
    Sci Eng Ethics; 2019 Jun; 25(3):791-811. PubMed ID: 29532279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to human embryonic stem cell patents.
    Plomer A; Taymor KS; Scott CT
    Cell Stem Cell; 2008 Jan; 2(1):13-7. PubMed ID: 18371416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patenting pieces of people.
    Nat Biotechnol; 2003 Apr; 21(4):341. PubMed ID: 12665804
    [No Abstract]   [Full Text] [Related]  

  • 11. Patentability of life and ethics.
    Lenoir N
    C R Biol; 2003; 326(10-11):1127-34. PubMed ID: 14744124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intellectual property on the biotechnology industry.
    Davis JH; Wales MM
    Adv Genet; 2003; 50():427-39; discussion 507-10. PubMed ID: 14714703
    [No Abstract]   [Full Text] [Related]  

  • 13. Monsters at the patent office: the inconsistent conclusions of moral utility and the controversy of human cloning.
    Smith AR
    De Paul Law Rev; 2003; 53(1):159-203. PubMed ID: 15568254
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent protection for microbial technologies.
    Sherkow JS
    FEMS Microbiol Lett; 2017 Nov; 364(20):. PubMed ID: 29029027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patenting of human embryonic stem cells in Europe.
    Treichel P
    Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
    [No Abstract]   [Full Text] [Related]  

  • 16. The Human Genome Project--promise and problems.
    Kirby M
    J Contemp Health Law Policy; 1994; 11(1):1-21. PubMed ID: 10142389
    [No Abstract]   [Full Text] [Related]  

  • 17. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
    Van Overwalle G
    Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
    [No Abstract]   [Full Text] [Related]  

  • 18. The morality of biotech patents: differing legal obligations in Europe?
    Ford R
    Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
    [No Abstract]   [Full Text] [Related]  

  • 19. Patenting DNA: who defines and protects the public good?
    Garcia SA
    Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850
    [No Abstract]   [Full Text] [Related]  

  • 20. Ruling on BRCA gene patents could have limited impact.
    Goozner M
    J Natl Cancer Inst; 2010 Jun; 102(11):754-7. PubMed ID: 20498427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.